Contribution of stem-like cells to angioproliferative pulmonary arterial hypertension in the SU5416/chronic hypoxia model

L. Farkas, D. Farkas, D. Kraskauskas, A. Alhussaini, V. Kraskauskiene, H. Bogaard, N. Voelkel (Richmond, United States Of America; Amsterdam, Netherlands)

Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Session: Pulmonary circulation: basic mechanisms, animal models and cell biology
Session type: Poster Discussion
Number: 3167
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Farkas, D. Farkas, D. Kraskauskas, A. Alhussaini, V. Kraskauskiene, H. Bogaard, N. Voelkel (Richmond, United States Of America; Amsterdam, Netherlands). Contribution of stem-like cells to angioproliferative pulmonary arterial hypertension in the SU5416/chronic hypoxia model. Eur Respir J 2012; 40: Suppl. 56, 3167

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension
Source: International Congress 2017 – Experimental PH
Year: 2017


Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
Year: 2021



Nestin-expressing vascular wall cells drive development of pulmonary hypertension
Source: Eur Respir J 2016; 47: 876-888
Year: 2016



Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006


Apoptosis and cell proliferation in chronic hypoxic pulmonary hypertension
Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms
Year: 2007


MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

An investigation of the origins of pulmonary artery lesion cells in pulmonary arterial hypertension rat models
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019

Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Pulmonary arterial hypertension and continuous injury of alveolar epithelial cells in COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006


Inflammation in pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: 358-363
Year: 2003



A novel murine model of severe pulmonary arterial hypertension
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010


Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic pulmonary hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008


Targeting cell motility in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 531-544
Year: 2013



Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007

Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
Source: Eur Respir J 2011; 38: 1453-1460
Year: 2011



Caspase inhibition reduces severe pulmonary hypertension in the AdTGF-1β/SU5416 model of angioproliferative pulmonary hypertension and lung fibrosis
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011